Buss et al., 1987 - Google Patents
Myristoylated alpha subunits of guanine nucleotide-binding regulatory proteins.Buss et al., 1987
View PDF- Document ID
- 5306404562920900411
- Author
- Buss J
- Mumby S
- Casey P
- Gilman A
- Sefton B
- Publication year
- Publication venue
- Proceedings of the National Academy of Sciences
External Links
Snippet
Antisera directed against specific subunits of guanine nucleotide-binding regulatory proteins (G proteins) were used to immunoprecipitate these polypeptides from metabolically labeled cells. This technique detects, in extracts of a human astrocytoma cell line, the alpha subunits …
- 230000027455 binding 0 title abstract description 9
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Buss et al. | Myristoylated alpha subunits of guanine nucleotide-binding regulatory proteins. | |
| Birge et al. | Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts | |
| Nigg et al. | Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide. | |
| Walsh et al. | The inhibitor protein of the cAMP-dependent protein kinase | |
| Yamamoto et al. | Purification and characterization of a GTP-binding protein with a molecular weight of 20,000 in bovine brain membranes. Identification as the rho gene product. | |
| US6994979B2 (en) | Conversion of apoptotic proteins | |
| JP2002511763A (en) | A screening method using an ATPase protein derived from a virus belonging to the family Flavivilidate | |
| Bresson et al. | Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases | |
| KR20000029469A (en) | Compounds that inhibit interaction between signal-transducing proteins and the glgf(pdz/dhr) domain and uses thereof | |
| JP3127996B2 (en) | Synthetic senescent cell antigen | |
| US6103692A (en) | Inhibiting protein interactions | |
| US20040072753A1 (en) | Peptides for use in the treatment of alzheimer's disease | |
| Mortillaro et al. | Matrin CYP, an SR-rich cyclophilin that associates with the nuclear matrix and splicing factors | |
| JP2000509967A (en) | Peptides from soluble forms of acetylcholinesterase active as calcium channel modulators | |
| WO1997034146A9 (en) | Inhibiting protein interactions | |
| Zauner et al. | Identification of the polypeptide encoded by the URF‐1 gene of Neurospora crassa mtDNA | |
| JP4286764B2 (en) | Virus morphogenesis inhibition method | |
| CA2471924C (en) | Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death | |
| Papanastasiou et al. | Primary structure and biochemical properties of a variant-specific surface protein of Giardia | |
| US5789382A (en) | Retro-peptide fibroblast growth factor which blocks FGF receptor | |
| Wainwright et al. | The membrane domain of the human erythrocyte anion transport protein. Epitope mapping of a monoclonal antibody defines the location of a cytoplasmic loop near the C-terminus of the protein | |
| US20070292907A1 (en) | Compositions and method for regulating ubiquitin-specific processing proteases | |
| MXPA05001364A (en) | Mk2 interacting proteins. | |
| Yee et al. | Biochemical characterization of the human cyclin-dependent protein kinase activating kinase: Identification of p35 as a novel regulatory subunit | |
| JP4995399B2 (en) | Cleaved BARD1 protein and its diagnostic and therapeutic uses |